Ellie Kincaid is an editor at Retraction Watch. Her work has appeared in STAT, The Wall Street Journal, Forbes, WebMD and Medscape. She has a B.A. in English from Washington University in St. Louis and an M.A. in journalism from New York University’s Science, Health and Environmental Reporting Program.
Ellie Kincaid
Editor
Retraction Watch
From this contributor
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
By
Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read
Head of company that accredits autism service providers resigns after article retraction
The resignation follows reporting by Spectrum and Retraction Watch in October about nonexistent references in the retracted article.
Head of company that accredits autism service providers resigns after article retraction
By
Ellie Kincaid
29 November 2023 | 4 min read
Article defending private-equity involvement in autism services retracted
Nearly two-thirds of the article’s references appear to not exist.
Article defending private-equity involvement in autism services retracted
By
Ellie Kincaid, Retraction Watch
19 October 2023 | 5 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read